APRI will go UP
$2.55 on 2/18/09
$2.25 (1.81% from time of market call)
With very few industries having a secure future in the markets, Medicine is one of those industries. Better than just medicine, being a research firm in the medical field is the best position to be in. With subsequent research that Nexmed is completing it is clear that this is not a company that is doing research just for the sake of doing it. The company seems to be studying areas that are of major interest to the community at large, and should continue to be an excellent stock to carry in your portfolio.